RS Platforms Ltd Surpasses
£9.02 Billion Valuation,
Cementing Status as a Global Deep-Tech Decacorn

CITY OF LONDON, UK — RS Platforms Ltd, a premier global conglomerate specializing in deep-tech, artificial intelligence, and advanced digital infrastructure, today officially announced that its post-money valuation has reached £9.02 Billion ($11.95 Billion USD). This historic financial milestone officially elevates the organization into the highly exclusive global “Decacorn” league of privately held technology enterprises.

Operating entirely from its global headquarters at 122 Leadenhall Street, London, this £9.02 billion valuation is a direct result of unprecedented global adoption and seamless technological deployment spanning over 55+ countries.

Over the past year, RS Platforms has witnessed explosive growth across its core digital and physical ecosystems. The valuation surge was primarily driven by the aggressive global scaling of high-performance computing infrastructure through RSP Cloud, the successful international deployment of the AI-powered hybrid healthcare platform Rsx Hospital, and groundbreaking advancements in bionic sensor interfaces developed by Rsx E Skin.

“This valuation is not merely a financial metric; it is a profound validation of our core philosophy—building the future through uncompromising science and engineering. Reaching the £9.02 billion mark ensures that we have the ultimate strategic leverage to accelerate our grandest visions. From revolutionizing human physiology with Rsx E Skin to bridging global digital divides with our upcoming Rsxlink satellite constellation, we are not just participating in the future; we are coding its foundation across the globe.”

The valuation milestone coincides with a period of rapid international expansion. Backed by a powerhouse team of over 500+ R&D scientists and engineers, RS Platforms is heavily reinvesting its capital to push the boundaries of what is technologically possible on a global scale.

“Crossing the £9 billion threshold is a testament to our highly scalable ecosystem model. By deploying bleeding-edge solutions like RSP Cloud and Rsx Hospital across 55+ countries, we have created unparalleled value for our enterprise partners and everyday consumers. Our immediate focus remains on executing our ambitious strategic roadmap and continuing to scale our operations flawlessly across international borders.”

Strategic Highlights & Future Outlook

Capitalizing on this new valuation, RS Platforms has outlined aggressive operational goals for its diverse portfolio:

RS Platforms remains strictly committed to its mission of bridging the gap between cutting-edge academia and real-world engineering, transforming complex sectors with tech-enabled ecosystems.

About RS Platforms Ltd

RS Platforms Ltd is a global innovation, science, and technology conglomerate headquartered in London, UK. Spanning multiple advanced industries including Artificial Intelligence, Aerospace, Cloud Computing (RSP Cloud), Advanced Healthcare (Rsx Hospital), Bio-sensors (Rsx E Skin), and Global Connectivity (Rsxlink), the RSX Group is dedicated to empowering the future through next-generation technological solutions worldwide.